Home Health Judging the Abortion Pill

Judging the Abortion Pill


The Host

Julie Rovner


Julie’s stories.

Julie Rovner is chief Washington correspondent and host of KHN’s weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to Z,” now in its third edition.

The eyes of the nation will be on Texas this week as a federal judge from Texas is expected to rule on whether the abortion pill, mifepristone, can remain on the market. Mifepristone, which is half of a 2-pill regimen, accounts for more that half of all abortions in the United States.

Novo Nordisk is another big drug company that dominates the diabetes treatment market. It has now announced that it will reduce the price of some of its insulin products. Eli Lilly made the announcements early in the month. However, activists and members in Congress are not the only ones pushing for affordable insulin. Because of the peculiarities in the drug market, cutting prices could actually help companies save money.

Continue reading…

Previous articleOpposite or anatomic overall shoulder for glenohumeral arthritis – does a preoperative MRI assist with the verdict?
Next articleAsparagus Risotto w/ Leeks and Peas